Neoadjuvant CCRT With Gemcitabine/Durvalumab (MEDI4736) Followed by Adjuvant Gemcitabine/Durvalumab(MEDI4736) in Resectable or Borderline Resectable Pancreatic Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to AstraZeneca
Related studies linked through entity extraction aliases.
Olaparib Before Surgery in Treating Participants With Localized Prostate Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Does Cediranib With Paclitaxel, or Cediranib and Olaparib, Treat Advanced Endometrial Cancer Better Than Paclitaxel?
- Status
- UNKNOWN
- Phase
- PHASE2
Effect of Benralizumab in Atopic Dermatitis
- Status
- COMPLETED
- Phase
- PHASE2
Study to Evaluate Concordance of Detecting EGFR (Epidermal Growth Factor Receptor) Mutation by Circulating Tumour Free DNA Versus Tissues Biopsy in NSCLC (Non-small Cell Lung Cancer).
- Status
- COMPLETED
- Phase
- N/A
S-CEI of Nexium in Paediatric Patients
- Status
- COMPLETED
- Phase
- N/A
Trial of Tremelimumab in Patients With Previously Treated Metastatic Urothelial Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study to Evaluate Efficacy and Safety of Benralizumab in Reducing Oral Corticosteroid Use in Adult Patients With Severe Asthma
- Status
- COMPLETED
- Phase
- PHASE3
Development of AECOPD Identification Tool (DETECT Study)
- Status
- COMPLETED
- Phase
- N/A
A Study of Esomeplazole (D961H) in Japanese Paediatric Patients With Reflux Esophagitis, Gastric Ulcer or Duodenal Ulcer
- Status
- COMPLETED
- Phase
- PHASE3
A Study Using Olaparib Tablets for Subjects With Advanced Solid Tumours.
- Status
- COMPLETED
- Phase
- PHASE1
iCaReMe Global Registry
- Status
- RECRUITING
- Phase
- N/A
A Study of Lanabecestat in Participants With Severe Kidney Impairment Compared to Healthy Participants
- Status
- WITHDRAWN
- Phase
- PHASE1
Cabozantinib Plus Durvalumab With or Without Tremelimumab in Patients With Gastroesophageal Cancer and Other Gastrointestinal Malignancies
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Durvalumab Plus Olaparib Administered Prior to Surgery of Resectable Urothelial Bladder Cancer (NEODURVARIB)
- Status
- COMPLETED
- Phase
- PHASE2
Olaparib Tablets Maintenance Monotherapy Ovarian Cancer Patients After Complete or Partial Response to Platinum Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE3
Clinical, Inflammatory and Functional Evaluation of a Population of Severe and Obese Asthmatics: Follow up
- Status
- UNKNOWN
- Phase
- NA
Potassium Reduction Initiative to Optimize RAAS Inhibition Therapy With Sodium Zirconium Cyclosilicate in Heart Failure
- Status
- TERMINATED
- Phase
- PHASE2
Fulvestrant Plus Abemaciclib in Women With Advanced Low Grade Serous Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Durvalumab With Radiotherapy for Adjuvant Treatment of Intermediate Risk SCCHN
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2